Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies.

ABSTRACT: Metastatic Prostate Cancer (mPCa) is associated with a poor patient prognosis. mPCa spreads throughout the body, often to bones, with spatial and temporal variations that make the clinical management of the disease difficult. The evolution of the disease leads to spatial heterogeneity that is extremely difficult to characterise with solid biopsies. Imaging provides the opportunity to quantify disease spread. Advanced image analytics methods, including radiomics, offer the opportunity to characterise heterogeneity beyond what can be achieved with simple assessment. Radiomics analysis has the potential to yield useful quantitative imaging biomarkers that can improve the early detection of mPCa, predict disease progression, assess response, and potentially inform the choice of treatment proce

SUBMITTER: Kendrick J 

PROVIDER: S-EPMC8591174 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature